引用本文: 冯俊超,张海琴,李顺平.普惠保参与罕见病保障的利益相关者分析与政策建议*[J].中国卫生经济,2023,42(12):23-27.[点击复制] Feng Junchao,Zhang Haiqin,Li Shunping.Stakeholder Analysis and Policy Recommendations for Inclusive Health Insurance Participation in Rare Disease Health Care Coverage[J].CHINESE HEALTH ECONOMICS,2023,42(12):23-27.[点击复制]
【打印本页】 查看/发表评论 关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 680次   下载 298 本文二维码信息
码上扫一扫!
普惠保参与罕见病保障的利益相关者分析与政策建议*
冯俊超,张海琴,李顺平
0
(山东大学齐鲁医学院公共卫生学院卫生管理与政策研究中心 济南 250012 ;国家卫生健康委员会卫生经济与政策研究重点实验室 (山东大学) 济南 250012 ;山东大学健康偏好研究中心 济南 250012;广西壮族自治区医学科学信息研究所卫生健康政策研究室 南宁 530022)
摘要:
目的:基于利益相关者视角,对普惠保参与罕见病保障的利益相关者进行识别,对存在的问题予以分析。方法:使用文献综述法和米切尔评分法进行利益相关者的识别、分型和关系分析,对已明确的主要利益相关者进行定性访谈, 探究其在参与普惠保过程中的诉求、定位与阻碍因素。结果:医疗保障局、银保监会与主承保公司为“确定型利益相关者”, 对普惠保发展影响最大。编码最终形成了 63条概念,并从利益诉求、角色、优势、难点和行为策略 5大范畴对各利益相关者进行分析和阐述。结论:各利益相关者之间诉求存在差异,职责不够明晰,有效协同程度不够。
关键词:  普惠保  罕见病  利益相关者  医疗保障
DOI:
投稿时间:2023-09-24
基金项目:国家自然科学基金面上项目 (72174110)
Stakeholder Analysis and Policy Recommendations for Inclusive Health Insurance Participation in Rare Disease Health Care Coverage
Feng Junchao,Zhang Haiqin,Li Shunping
()
Abstract:
Objective: To conduct stakeholder identification and problem analysis of inclusive health insurance participation in rare disease coverage based on the stakeholder perspective. Methods: A literature review and a Mitchell scale were used to identify, categorize, and analyze the relationship among the stakeholders, and qualitative interviews were conducted with identified stakeholders to explore their demands, positioning, and barriers to participation in inclusive health insurance. Results: The Healthcare Security Ad- ministration, Banking and Insurance Regulatory Commission, and the primary insurer were the most influential “identified stakehold- ers” in the development of inclusive health insurance. A total of 63 concepts were coded, and the stakeholders were analyzed and de- scribed in categories of claims, roles, strengths, difficulties, and behavioral strategies. Conclusion: There were differences in the de- mands of the stakeholders, lack of clarity of roles, and lack of effective synergy.
Key words:  inclusive insurance  rare disease  stakeholder  medical insurance

用微信扫一扫

用微信扫一扫